Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights

Genes
Justin E IdeozuHara Levy

Abstract

In cystic fibrosis (CF), mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene disrupt the capacity of the encoded protein to function as a channel to transport chloride ions and water across cell membranes. The consequences are deleterious, system-wide, and immensely variable, even among patients with the same CFTR genotype. This underscores the need to characterize the mechanisms contributing to CF pathophysiology. Gene replacement and gene editing therapies have been pursued intensively and are expected to provide a one-time treatment for CF. However, gene replacement therapy is limited by the lack of efficient vectors to deliver functional copies of CFTR to cells without immunological complications, while gene editing technologies such as CRISPR/Cas9 are still in their infancy, mainly useful in somatic cells and limited by off-target insertions. Small molecule treatments targeted at potentiating or correcting CFTR have shown clinical benefits, but they are limited to a few CFTR mutations and insufficient to overcome challenges related to clinical heterogeneity. Transcriptome profiling approaches have emerged as robust tools capable of characterizing phenotypic variability and revealing novel molec...Continue Reading

References

Aug 21, 1992·Science·J N SnouwaertB H Koller
Mar 21, 1998·Human Molecular Genetics·A Harris
Jul 21, 2001·Twin Research : the Official Journal of the International Society for Twin Studies·F MekusB Tümmler
Apr 15, 2006·American Journal of Respiratory Cell and Molecular Biology·Jerry M WrightMichael P Boyle
Jan 16, 2007·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Catherine VerhaegheVincent Bours
May 1, 2007·Biochemical Pharmacology·Catherine VerhaegheVincent Bours
Feb 26, 2009·Cell·Chris P PontingWolf Reik
Oct 23, 2009·Proceedings of the National Academy of Sciences of the United States of America·Fredrick Van GoorPaul Negulescu
Jan 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Irene K OglesbyCatherine M Greene
Jan 21, 2010·Cell·Christina KielLuis Serrano
Mar 13, 2010·The Journal of Pathology·Danielle GlickKay F Macleod
Feb 2, 2011·The Journal of Biological Chemistry·Sharmistha BhattacharyyaRoopa Biswas
Jun 28, 2011·BMC Bioinformatics·Christopher R BolenSteven H Kleinstein
Oct 26, 2011·Antimicrobial Agents and Chemotherapy·Paul M BeringerDavid Z D'Argenio
Mar 10, 2012·American Journal of Respiratory Cell and Molecular Biology·Dmitry Ratner, Christian Mueller
Jul 24, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Thomas H HamptonBruce A Stanton
Dec 25, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Matthew L MayerRobert E W Hancock
Mar 19, 2014·The International Journal of Biochemistry & Cell Biology·Paul J McKiernanCatherine M Greene
Aug 28, 2014·Drug Development Research·Zainab KhatoonFeng Cheng
Oct 21, 2014·PloS One·Julie ChesnéUNKNOWN COLT Consortium
Nov 9, 2014·American Journal of Physiology. Lung Cellular and Molecular Physiology·James F Collawn, Sadis Matalon
Jan 30, 2015·Wiley Interdisciplinary Reviews. RNA·Benjamin Cieply, Russ P Carstens
Feb 13, 2015·Frontiers in Genetics·Alexander F Palazzo, Eliza S Lee
Mar 26, 2015·Frontiers in Oncology·Itamar Kanter, Tomer Kalisky
May 17, 2015·Advanced Drug Delivery Reviews·Scott M Hammond
Sep 4, 2015·Pediatric Pulmonology·Hongmei MouJayaraj Rajagopal
Oct 4, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Na Xie, Gang Liu
Oct 21, 2015·Biopreservation and Biobanking·Latarsha J Carithers, Helen M Moore
Mar 17, 2016·Trends in Molecular Medicine·Adam J ByrneClare M Lloyd
Apr 1, 2016·BMJ : British Medical Journal·Bradley S Quon, Steven M Rowe
Jun 23, 2016·Drug Discovery Today·Lucy F Donaldson, Nicholas Beazley-Long
Jul 20, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sheena M SaaymanKevin V Morris
Nov 9, 2016·Methods in Molecular Biology·Irene K Oglesby, Paul J McKiernan

❮ Previous
Next ❯

Methods Mentioned

BETA
scRNA-Seq

Software Mentioned

RNA
Sequencing

Related Concepts

Related Feeds

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.